Clinical Trials · NCT07203677
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 49,065
- Start date
- Sep 2025
- Locations
- 1 site, United States
- Primary endpoint
- Major adverse cardiovascular events